|
ZNF642 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.222800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.269570E-02 |
| Normal-vs-Stage2 |
1.145950E-02 |
| Normal-vs-Stage3 |
7.621100E-03 |
| Normal-vs-Stage4 |
1.410160E-02 |
| Stage1-vs-Stage2 |
5.333600E-01 |
| Stage1-vs-Stage3 |
3.934400E-01 |
| Stage1-vs-Stage4 |
5.187600E-01 |
| Stage2-vs-Stage3 |
9.758000E-01 |
| Stage2-vs-Stage4 |
9.893800E-01 |
| Stage3-vs-Stage4 |
9.871200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.702700E-03 |
| Normal-vs-AfricanAmerican |
5.538300E-02 |
| Normal-vs-Asian |
1.397410E-01 |
| Caucasian-vs-AfricanAmerican |
9.409600E-01 |
| Caucasian-vs-Asian |
3.164000E-01 |
| AfricanAmerican-vs-Asian |
4.861200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.946580E-01 |
| Normal-vs-Female |
7.561100E-04 |
| Male-vs-Female |
9.419300E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.184110E-02 |
| Normal-vs-Age(41-60Yrs) |
1.604750E-03 |
| Normal-vs-Age(61-80Yrs) |
3.357600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.611970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.460800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.197800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.359400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.212600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.210600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.219000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.307600E-01 |
| Classical-VS-Follicular |
6.973600E-02 |
| Classical-VS-Other |
8.279400E-01 |
| Classical-VS-Normal |
2.665500E-02 |
| Tall-VS-Follicular |
2.306800E-01 |
| Tall-VS-Other |
8.547000E-01 |
| Tall-VS-Normal |
1.085580E-01 |
| Follicular-VS-Other |
6.867600E-01 |
| Follicular-VS-Normal |
3.664400E-03 |
| Other-VS-Normal |
2.791600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.562100E-03 |
| Normal-vs-N1 |
7.743100E-03 |
| N0-vs-N1 |
8.617600E-01 |
|
|
